Recombinant human activated protein C
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human activated protein C, covering 2011-03-16 to 2011-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS) [NA]